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Abstract
Objective—Puerto Rico’s (PR) epidemiological data on each oral cavity and pharynx cancer 
(OCPC) site is yet largely unexplored. Our aim was to compare OCPC incidence in PR, by 
anatomical site, with that of non-Hispanic whites (NHW), non-Hispanic blacks (NHB), and 
Hispanic (USH) individuals in the USA.
Methods—Data from the Surveillance Epidemiology and End Results program and the PR 
Central Cancer Registry were collected and analyzed. Age-standardized rates, percent changes, 
and standardized rate ratios were estimated with 95% confidence intervals.
Results—Although declining incidence rates were observed for most anatomical sites in most 
racial/ethnic groups and in both sexes, the incidence of oropharynx cancers, slightly increased for 
cancers in the oropharynx among PR women, both in the base of tongue and soft palate/other 
oropharynx (p>0.05). The incidence of soft palate/other oropharynx cancers in PR men was about 
2.8 times higher than in USH men (p<0.05) and about 1.4 times higher than in NHW men but 21% 
lower than in NHB men (p>0.05). Significant interactions terms formed with racial/ethnic group 
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and age were shown in various sites. The largest differences between sexes were consistently 
noted in PR.
Conclusion—Further research in PR should assess the effect of the HPV infection, as well as of 
other risk factors, in OCPC incidence by anatomical site in younger populations. These data could 
explain more precisely the reasons for the differences observed in this study, particularly among 
sexes in PR.
Indexing terms
Oral cavity and pharyngeal cancer; SEER; Puerto Rico; Incidence; Trends
INTRODUCTION
Oral cavity and pharyngeal cancer (OCPC), as a group, is the sixth most common cancer in 
the world.1 Worldwide, the annual estimated incidence is approximately 275,000 for oral 
cavity cancers and 130,300 for pharyngeal cancers, excluding those of the nasopharynx.2 
However, OCPC incidence rates vary up to 20-fold according to geographic location.1 
Among all Caribbean islands, for example, Puerto Rico (PR) has the highest reported age-
adjusted (World standard) OCPC incidence (8 per 100,000 inhabitants; excluding 
nasopharynx) even slightly higher than in the United States of America (USA) (7.2 per 
100,000 inhabitants; excluding nasopharynx).3
According to the PR Central Cancer Registry (PRCCR), OCPC is the fourth and twelfth 
most common cancers among Puerto Rican men and women, respectively; approximately 
357 cases (273 men and 84 women) are diagnosed each year.4 From 1992 to 2002, the 
OCPC incidence among Puerto Rican women increased by 5.3% each year whereas among 
Puerto Rican men remained constant (p > 0.05).5 In the USA, on the other hand, the OCPC 
incidence in women decreased by approximately 1% per year from 1992 to 2008, and the 
OCPC incidence in men decreased by approximately 1.4% per year from 1992 to 2006, 
although some differences have been observed according to race, sex, and anatomical site.6
Various known risk factors such as alcohol use, tobacco use, human papillomavirus (HPV) 
exposure, poor nutrition, and poor oral hygiene may influence the trends of OCPC incidence 
in PR and the USA. In fact, some of these factors (e.g., HPV exposure and tobacco use) have 
been more closely associated with OCPC incidence at certain anatomical sites.7,8 Hence, 
determining the incidence of OCPC in PR by anatomical site and comparing it with that in 
non-Hispanic white (NHW), non-Hispanic black (NHB), and Hispanic (USH) Americans 
may help to determine where to focus our cancer prevention and control efforts to reduce the 
OCPC burden in PR. Thus, our aim was to assess the age-standardized OCPC incidence by 
anatomical site in PR and contrast these statistics with national data for USH, NHW, and 
NHB groups in the USA as reported by the Surveillance, Epidemiology, and End Results 
(SEER) program from 1992 to 2009.
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Data from the SEER program and the PRCCR were collected and analyzed as previously 
described in various studies.5,9,10 The PRCCR, part of the National Program of Cancer 
Registries, is administered by the Centers for Disease Control and Prevention (CDC) and 
uses the coding standards of the SEER program and the North American Association of 
Central Cancer Registries. Therefore, PRCCR data are fully comparable with SEER data. 
According to a CDC audit, in 2003, 95.3% of all cancer cases diagnosed or treated in 
hospital facilities in Puerto Rico were appropriately reported to the PRCCR, which is 
comparable to the proportion in the USA (95%).11
The criteria specified in the third revision of the International Classification of Diseases for 
Oncology (ICD-O-3) were used to select cases of OCPC from 2001 and later for this 
analysis.12 Cases from 1992–2000 were initially reported using ICD-O-2 and later converted 
to ICD-O-3 by the SEER program.13 This study was approved by the University of Puerto 
Rico Medical Sciences Campus Institutional Review Board.
Study population
Individuals older than 39 years and diagnosed with OCPC at three different primary sites: 1) 
oral cavity [oral tongue (C020–C023), floor of mouth (C040–C049), and gingivobuccal 
(C030–C039,C050, and C060–C069)], 2) oropharynx [base of tongue (C019 & C024), tonsil 
(C090–C099), and soft palate/other oropharynxC(051–C052,C100–C109)], and 3) 
hypopharynx (C129, C130–C139) were included in the analyses. Cases of lip, salivary 
gland, and nasopharynx cancer were not included given their different epidemiologic 
characteristics.7 Moreover, patients with cancers in other ill-defined sites in the lip, oral 
cavity, and pharynx were excluded from this study because the number of these cases 
diagnosed in PR during the study period was rather small (1992–2009; 77 in women and 347 
in men). This study did not account for ethnic differences within the USH population.
Statistical Analysis
Using the world standard population as a reference, we applied the direct method to compute 
the age-standardized rates [ASR (World)] for each OCPC anatomical site during 1992–
2009.15 The change in the ASR (World) for each OCPC anatomical sites from the earliest 
and the latest study period (1992–1998 and 2003–2009) was calculated as a percent change 
(PC) as follows:
A Bonferroni test adjusted for multiple comparisons was performed using 99.4% confidence 
for eight comparisons (two sex categories and four racial/ethnic groups), for each site, in 
order to assess the significance change of the PCs. As a consequence, the overall significant 
type I error was approximately 5%. The confidence intervals (CIs) were calculated with the 
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formulas recommended by the U.S. Census Bureau.16 Significant changes were declared 
with p<0.05 for each anatomical site if 0 was not included in the interval.
We also assessed racial/ethnic group differences in OCPC incidence by anatomical sites, 
during2005–2009, by estimating the ratio of two standardized rates  between 
sexes (i = men and j = women) and any two groups (i = PR and j = other racial/ethnic group) 
with 95% CIs.17 This ratio is referred to as the standardized rate ratio (SRR). A likelihood 
ratio test was used to formally assess the interaction terms between the predictor variables 
(sex and age-group) in the Poisson regression model in order to determine if the age-specific 
rates were different. The statistical analysis was performed using Stata/SE statistical 
software version 11.0 (Stata Corp., L.P., College Station, TX).
RESULTS
Age Standardized Rates (World)
The incidence of each OCPC anatomical site during 1992–2009 is shown in Table 1. 
Although declining incidence rates were observed for most anatomical sites in most racial/
ethnic groups and in both sexes, the incidence of oropharynx cancers, mainly base of tongue 
(PC = 62.3) and tonsil (PC = 64.3), significantly increased in NHW men from 1992–1998 to 
2003–2009 (p<0.05; Table 2). PR also showed a slight increase for cancers in the 
oropharynx among women, both in the base of tongue and soft palate/other oropharynx 
(p>0.05; Table 2). Among women, PR showed the larger increase for cases of oral tongue 
cancers (PC = 40.5; p>0.05) and the only group with increasing trends of floor of mouth 
cancers (PC = 9.2; p>0.05). Hispanic men, both Puerto Ricans (PC=18.7) and USH (PC = 
7.8), were the only groups with increasing trends of gingivobucccal cancers (p>0.05). 
Cancers from all OCPC sites diminished among NHB (Table 2). Hypopharynx cancers 
declined in all racial/ethnic groups (Table 2).
Standardized Rates Ratios
During 2005–2009, the incidence of OCPC at any anatomical site was consistently lower in 
Puerto Rican women than in any other group (Table 3). Among men, however, the OCPC 
incidence in PR varied compared to that among USH and NHW. For example, the incidence 
of soft palate/other oropharynx cancers in Puerto Rican men was about 2.8 (95%CI = 2.08, 
3.91) times higher than in USH men and about 1.4 (95%CI = 1.20, 1.71) times higher than 
in NHW men but 21% (SRR: 0.79; 95%CI = 0.62, 1.00) lower than in NHB men. 
Accordingly, the incidence of cancer in oropharyngeal sites in men was slightly higher in PR 
than in USH (p>0.05). Likewise, men in PR had about 28% (SRR: 1.28; 95%CI = 0.91, 
1.82) higher incidence of floor of mouth cancer as compared to USH men. All OCPC sites 
showed lower SRR in PR than NHB (Table 3).
Despite these findings, significant interactions terms formed with racial/ethnic group and 
age were shown in various sites (p<0.05). For example, among men the oral cavity and 
oropharynx sites showed higher cancer incidence among those individuals between 40–49 
years old and 50–59 years old in PR as compared to USH [data not shown]. The incidence of 
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cancers of the soft palate/other oropharynx among individuals older than 70 years of age was 
about 25% lower in PR than in USH and NHW (p>0.05; data not shown) whereas among 
younger individuals (40–69 years of age) the relative risks (RR) ranged from 1.39 to 5.21 
(p<0.05; data not shown). Younger women (40–49 years old) in PR showed higher risks of 
oropharynx cancer than USH women of the same age group (RR: 2.39; 95%CI = 1.12, 5.07) 
[data not shown]. Likewise, the incidence of soft palate/other oropharynx cancers among 
women in PR between 40–49 years old (RR: 8.86; 95%CI = 0.99, 79.28) and 50–59 years 
old (RR: 1.03; 95%CI = 0.28, 3.85) was higher than in USH women. Most of the sites 
showed an inverse dose-response relationship among those racial/ethnic groups’ 
comparisons with significant interactions terms in the Poisson model [data not shown].
In all racial/ethnic groups and at all anatomical sites, the incidence of OCPC was higher in 
men than in women; this excess was not significant (p>0.05) neither for oral tongue cancer 
in USH nor for gingivobuccal cancer in NHB (Table 4). The largest differences in OCPC 
incidence between sexes were consistently noted in Puerto Rican individuals except for base 
of tongue cancers (Table 4); it was manly observed for cancer of the hypopharynx (SRR: 
29.6; 95% CI = 14.1, 86.3). For each racial/ethnic group, various sites showed significant 
interaction terms formed with sex and age (p<0.05). Those individuals between 60–69 years 
old in PR and 50–59 years old in NHW showed higher RR in men than in women [data not 
shown]. Also, the incidence floor of mouth cancer among USH men was much higher than 
in USH women for those between 60–69 years old (RR: 11.1; 95%CI = 2.6, 47.6) [data not 
shown]. NHB had the highest difference between sexes for tonsil cancer among individuals 
that were ≥ 70 years of age (p<0.05; data not shown).
DISCUSSION
The results of this study indicate that the incidence of OCPC by anatomical site in PR differs 
from that in other racial/ethnic groups in the continental USA. Differences in OCPC 
incidence between PR and continental USA by anatomical site could be the result of 
differences in the prevalence of OCPC risk factors in these populations, including smoking, 
alcohol drinking, poor oral hygiene, poor dietary habits, HPV infection, and risky sexual 
behaviors. Furthermore, we cannot discount genetic predisposition as a relevant factor; for 
example, a study conducted in PR18 indicated that in persons with the GSTT1-present 
genotype, the risk of oral cancer increased as cigarette use increased. However, to our 
knowledge, no studies have shown that the frequency of genetic polymorphisms associated 
with oral cancers is different in Puerto Rican and American individuals.
In addition, the lower incidence of certain OCPC (i.e. soft palate/other oropharynx and floor 
of mouth) in USH men than in Puerto Rican men could be the result of what is known as the 
“healthy migrant effect,” which suggests that people who migrate are healthier than those 
who remain in their countries of origin.19 The fact that USH individuals may possess better 
health-enhancing behavioral profiles19 may influence the incidence rates in this USA 
population. Nonetheless, given that in our study, we only observed such patterns among 
men; further research is warranted to determine whether this hypothesis in fact applies only 
to men and to elucidate the reasons for this sex-based disparity between Puerto Rican and 
USH individuals.
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Despite the differences found, for all racial/ethnic groups the most common cancer was the 
tonsils followed by the soft palate/other oropharynx among men in PR and the base of 
tongue among men in the continental USA. On the other hand, in all racial/ethnic groups, 
women mainly had cancers in the gingivobuccal subsite followed by the tonsils in Puerto 
Rican and NHB women and the oral tongue in USH and NHW women. An increase in the 
incidence of cancers in the tonsils and oral tongue was previously observed in NHW 
individuals from 1975–1982 to 1992–199820 and, as seen in our study, the incidence of these 
cancers continues increasing in this group among men and women, respectively. Also, other 
researchers have found that the incidence of oral tongue, base of the tongue and tonsil 
squamous cell carcinomas has increased over time.21 Squamous cell carcinoma of the tonsil 
and the base of tongue has previously been associated with HPV.22–24 OCPC of the 
oropharynx has also been related to HPV, and our findings suggest the incidence of 
oropharyngeal cancers is slightly increasing among women older than 39 years old in PR but 
not in the continental USA. However, Puerto Rican women presented lower risks of 
oropharyngeal cancers than any other racial/ethnic group in the continental USA; only 
women between 40–49 years old in PR showed higher risks (RR: 2.39; 95%CI = 1.12–5.07) 
than USH women within the same age group. Higher risks were also found for 
oropharyngeal cancers among men in PR when compared to USH men between the 40–49 
and 50–59 age groups. Soft palate/otheroropharynx cancers as well showed higher risks in 
younger groups when comparing PR to NHW and USH. These findings could suggest not 
only differences in HPV infection but also in sexual behaviors between the groups, because 
various studies have found that an increasing number of lifetime sex partners is associated 
with an increasing risk of oropharyngeal cancer; the risk of oropharyngeal cancer is 
increased by 34-fold in individuals with more than 9 lifetime sex partners.25
Population-based data on oral HPV infection are not available for PR, so we cannot make a 
direct comparison with the data of the USA, based on the National Health and Nutrition 
Examination Survey (NHANES).26 Nonetheless, a population-based study performed in PR 
during 2005–2008 suggested that oral sex practices and higher numbers of sexual partners 
could be more prevalent in PR than in Mexican Americans in the USA.27 Hence, monitoring 
the impact of HPV vaccines28 on the trends in oropharyngeal cancer incidence in PR and the 
continental USA may be of interest. However, given the low uptake of the vaccine,29,30 the 
impact of vaccination on disease trends may be delayed.
The decline in the incidence of cancers of the hypopharynx, floor of the mouth, and 
gingivobuccal in the mouth from 1992–1998 to 2003–2009 is consistent with the declines in 
smoking and alcohol consumption, which are the major risk factors for OCPC.31 According 
to the Behavioral Risk Factor Surveillance System survey, from 1997 to 2010, tobacco 
consumption declined in PR (14.4% to 11.9%) and in the USA (23.2% to 17.3%).32 
Moreover, a small fluctuation in the prevalence of heavy alcohol drinking was observed in 
Puerto Rico (3.8% to 3.0%) and the USA (5.1% to 5.0%) from 2001 to 2010.32 Nonetheless, 
caution must be taken when considering these prevalence estimations as a possible 
justification for declining trends in the incidence of cancer at these sites, since there could be 
a delay of several years between exposure and the development of these cancers. These 
lifestyles (smoking and alcohol drinking) could partly explain the observed sex-based 
differences in OCPC incidence, as the risk of OCPC that is attributed to these factors is 
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about 76% (95% CI = 65–87%) for men and 52% (95% CI = 28–75%) for women.33 
However, we cannot discount the existence of other differences between men and women 
regarding the prevalence of other factors that may influence disease trends, such as HPV 
infection, sexual behaviors, and preventive care use, that may have also influenced our 
results.
The preventive care use, specifically dental checkups, is lower in men than in women in the 
USA34 so it could potentially explain sex-based differences in OCPC incidence at different 
anatomical sites. During the early 1990s, Marshall and colleagues35 found that poor oral 
hygiene also increases the risk of OCPC but to a lesser degree than do smoking and alcohol 
drinking. Poor oral hygiene can result in periodontitis, which has been related to oral 
premalignant lesions and OCPC. According to Lissowska et al.,36 the attributable risk of 
OCPC for low frequency of tooth brushing and dental checkups is about 56% and 47%, 
respectively. This chronic inflammatory disease (i.e., periodontitis) could affect tissues at 
distant sites through periodontal bacteria, via saliva and the bloodstream, and cause tissue 
injury through inflammatory reactions.37–39 Furthermore, an oral inflammatory disease may 
lead to enhanced penetration of other carcinogens (e.g., tobacco, alcohol, and dietary 
metabolites)40 as well as the acquisition and persistence of oral HPV infection.41
According to NHANES, during 2009–2010 the prevalence of oral infection with any of 37 
HPV DNA types evaluated was significantly higher among men than women (10.1% vs. 
3.6%; p < 0.05)26, and this disparity may be related to the number of sexual partners. In fact, 
Ortiz and colleagues27 reported that the prevalence of multiple sexual partners (≥7 lifetime 
partners) is higher in men than in women in PR (47.9% and 13.2%, respectively). Thus, this 
pattern may contribute to explain the largest sex-based differences in OCPC incidence 
among Puerto Ricans, particularly for anatomical sites related to HPV infection.
To our knowledge, this is the first study to describe OCPC incidence by anatomical site in 
PR and compare it with that of other racial/ethnic groups in the USA. Nonetheless, some 
limitations of this study should be acknowledged. First, we were unable to collect 
information regarding risk factors for OCPC for any of the racial/ethnic groups. 
Nevertheless, our findings suggest different behavior patterns in PR that could be affecting 
our OCPC incidence rates in each site. Second, our results may have been influenced by 
poor accuracy in the classification of Hispanic cancer cases in the SEER 13 program. 
However, this bias can be reduced by combining surname and medical record information.42 
Because this method is used by the SEER 13 program when classifying persons as USH 
individuals,43 we do not expect our conclusions to be affected. Last, reduced cancer 
reporting by the Department of Veterans Affairs hospitals impacted the most recent USA 
and Puerto Rican cancer surveillance data (2005-present).44 Even though incidence rates 
after 2004 may be underestimated, differences between Puerto Ricans and the other racial/
ethnic groups in the USA are expected to remain the same, as both groups were affected by 
underreporting.
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The incidence of each OCPC anatomical site in PR differed from that in NHW, NHB, and 
USH in the USA. Our study showed that younger individuals in PR had higher risks of 
oropharyngeal cancers, particularly in the soft palate/other oropharynx, than USH (both 
sexes) and NHW (only women) of the same age group. Therefore, further research in PR 
should assess the effect of the HPV infection, as well as of other risk factors, in OCPC 
incidence by anatomical site in younger populations. Another important finding was the 
risks differences between sexes, particularly in PR which showed the most extreme ratios. 
Thus, future research should also consider assessing the interaction between sex and 
different risk factors on different OCPC sites. These data could explain more precisely the 
reasons for the differences observed in this study and could provide relevant data that would 
help to identify future recommendations aimed at reducing the burden of OCPC in PR.
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Table 4
Standardized rate ratios for oral cavity and pharynx cancer by anatomical sites and racial/ethnic group, 2005–
2009.
SRR Men vs. Women (95% CI)
Anatomical site PR USH MHW NWB
Oral Cavity 3.06*† (2.38, 3.98) 1.63* (1.34, 2.00) 1.71*† (1.59, 1.83) 1.95* (1.58, 2.27)
  Oral tongue 2.19* (1.34, 3.75) 1.04 (0.74, 1.45) 1.59* (1.42, 1.78) 2.08* (1.39, 2.78)
  Floor of mouth 7.26* (4.15, 14.27) 3.27*† (2.05, 5.45) 2.62*† (2.26, 3.05) 3.35* (2.25, 4.25)
  Gingivobuccal 2.40*† (1.72, 3.41) 1.77* (1.32, 2.40) 1.44*† (1.30, 1.60) 1.33 (0.98, 1.74)
Oropharynx 6.30*† (4.84, 8.44) 4.16* (3.35, 5.22) 4.93*† (4.60, 5.28) 3.94* (3.36, 4.31)
  Base of tongue 4.48* (2.92, 7.32) 4.37* (3.04, 6.51) 5.36* (4.82, 5.98) 4.11* (3.14, 4.75)
  Tonsil 6.31* (4.09, 10.50) 4.62* (3.39, 6.46) 5.78*† (5.20, 6.45) 4.69*† (3.62, 5.35)
  Soft palate/Other 8.96*† (5.58, 15.96) 2.83* (1.73, 4.86) 2.61*† (2.24, 3.06) 2.85* (2.10, 3.45)
Hypopharynx 29.61* (14.09, 86.27) 9.57* (5.58, 18.43) 3.81* (3.24, 4.52) 6.93* (4.84, 8.10)





Interaction between age and sex was found (P < 0.05)
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